Significant Insider buy of Humanigen (HGEN) Shares Breaks neutral Trend of Last Quarter

Monday, March 05, 2018 10:15 PM ET

Significant Insider buy of Humanigen (HGEN) Shares Breaks neutral Trend of Last Quarter

One Humanigen insider — Nomis Bay Ltd, 10% Owner — today, acquired 29,893,424 shares having a market value of approximately $8,370,159, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

The number of buy-sell trades for Humanigen is close to that of the 45 member peer company average. The Biopharmaceuticals peer group saw 55 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares per buy/sell trade transacted by Humanigen insiders is higher. Within the peer group there were 1,859,423 shares purchased and 17,175,769 shares sold with company insiders having sold 278,479 shares on average.

The data sourced in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.